Comparison of two methods with and without creasing of part of the stomach in patients with morbid obesity
- Conditions
- Morbid obesity.Body mass index (BMI) 40.0-44.9, adult.Z68. 41
- Registration Number
- IRCT20201201049551N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Age 18-65 years
Obesity with a BMI of more than 35 with comorbidity disease or more than 40 kg / m2
Obesity with comorbidity diseases
Patients with consent to participate in the study
Debilitating diseases, including cancer, tuberculosis, AIDS
Having diseases that limit patient-physician communication, such as Alzheimer's
Recorded history of mental illness (major depression or uncontrolled psychosis)
Drug and alcohol abuse
Severe heart disease with risk of anesthesia
Severe coagulopathy
Not accepting nutritional orders
History of gastric surgery or antireflux surgery
High-grade dysplasia in Barrett's esophagus
Severe iron deficiency anemia
Distal lesions of the stomach or duodenum require follow-up
Patients with no consent to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight Loss. Timepoint: Two weeks, 1,2,6, 12 months after surgery. Method of measurement: The rate of weight loss two weeks after surgery is 4%, 1 month after 8%, 3 months after 18%, 6 months after 30%, 12 months after 40% relative to baseline weight.
- Secondary Outcome Measures
Name Time Method The amount of ghrelin hormone. Timepoint: Six, 12 months after surgery. Method of measurement: Pg/mL.